Could extra doses of abatacept stop severe transplant complications?
NCT ID NCT04380740
First seen Feb 21, 2026 · Last updated May 23, 2026 · Updated 9 times
Summary
This study tests whether giving more doses of the drug abatacept after a stem cell transplant can better prevent severe graft-versus-host disease (GVHD), a serious complication where donor cells attack the patient's body. About 160 people aged 2 and older receiving a partially matched donor transplant will be randomly assigned to get either 4 or 8 doses of abatacept, plus standard medications. Researchers will track how many patients stay free of severe GVHD and relapse for at least one year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAFT VS HOST DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beth Israel Deaconess Medical Center
ACTIVE_NOT_RECRUITINGBoston, Massachusetts, 02215, United States
-
Boston Children's Hospital
RECRUITINGBoston, Massachusetts, 02115, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Children's Healthcare of Atlanta
RECRUITINGAtlanta, Georgia, 30329, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Children's Hospital of Philadelphia
WITHDRAWNPhiladelphia, Pennsylvania, 19104, United States
-
Cincinnati Children's Hospital
ACTIVE_NOT_RECRUITINGCincinnati, Ohio, 45229, United States
-
City Of Hope National Medical Center
ACTIVE_NOT_RECRUITINGDuarte, California, 91010, United States
-
Dana-Farber Cancer Institute
ACTIVE_NOT_RECRUITINGBoston, Massachusetts, 02215, United States
-
Emory University/Winship Cancer Center
ACTIVE_NOT_RECRUITINGAtlanta, Georgia, 30322, United States
-
Massachusetts General Hospital
ACTIVE_NOT_RECRUITINGBoston, Massachusetts, 02114, United States
-
Moffitt Cancer Center
ACTIVE_NOT_RECRUITINGTampa, Florida, 33612, United States
-
Oregon Health and Sciences University
ACTIVE_NOT_RECRUITINGPortland, Oregon, 97239, United States
-
University of Chicago
RECRUITINGChicago, Illinois, 60637, United States
Contact
Contact
-
University of Michigan
ACTIVE_NOT_RECRUITINGAnn Arbor, Michigan, 48109, United States
-
University of Rochester
RECRUITINGRochester, New York, 14642, United States
Contact Email: •••••@•••••
Contact
-
Washington University St. Louis
WITHDRAWNSt Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.